Cognizant Technology Solutions Corporation

Independent institutional-style research note that triangulates valuation across DCF, Monte Carlo, peer re‑rating and scenario analysis, assigning CTSH a SELL rating with a probability-weighted 12‑month value around 39 USD and a triangulated fair value of 45 USD, only modestly above spot. It highlights a structural “AI‑driven services deflation” bear case with a target near 17 USD, arguing gross margin is the key swing factor and that downside scenarios carry enough weight to skew the risk/reward unfavorably despite strong free cash flow and a net cash balance sheet.

Value-investing article positioning CTSH as an attractive opportunity, citing an Acquirer’s Multiple of 5.9, an IV/P of 1.10, and strong free cash flow of about 2.47 billion USD alongside conservative leverage and substantial equity as evidence of undervaluation. While acknowledging risks from slowing IT spend, competition and AI disruption, it argues the market is overly focused on near-term headwinds and underappreciates Cognizant’s durable enterprise relationships, cash generation and shareholder-return capacity.

DBS’s US equity research report maintains a BUY rating with a revised 12‑month target price of 66 USD, based on an 11x forward P/E applied to roughly 2.8 billion USD of blended net profit and implying a valuation discount versus global IT services peers. The note emphasizes robust bookings (around 29.6 billion USD TTM with book‑to‑bill near 1.4x), modest mid‑single‑digit revenue CAGR and incremental margin expansion driven by the NextGen and Project Leap efficiency programs, while flagging risks from financial services weakness and potential global recession‑driven IT spending cuts.

Dividend-focused research report that rates CTSH as a Hold but models approximately 19% expected annual total returns over five years, driven by 5% EPS growth, a roughly 2.5% dividend yield and an 11.9% annualized gain from re‑rating to a fair P/E of 16x versus the current 9.1x. It stresses Cognizant’s long track record of double‑digit growth, resilient cash generation and undervalued multiple, while citing CEO turnover, elevated employee attrition and market fears of AI‑driven disruption as key ongoing risk factors.

Long-form fundamental analysis that reviews CTSH’s income statement, ratios and competitive positioning, concluding the company remains a value creator with ROIC around 12.3% versus a WACC near 7.9%, solid liquidity and conservative leverage, but notes a gradual decline in ROE/ROIC and net margin pressure through 2025. The piece highlights moderate valuation (P/E about 17.9, P/B about 2.66), a bearish 12‑month price trend with seller‑dominated volume, and mixed but generally positive analyst sentiment, leading to a cautiously constructive view that sees long‑term appeal but recommends careful timing given near-term volatility and competitive/technology risks.

Broker research note on Q3CY25 reporting constant‑currency revenue growth of about 7.4% year‑on‑year to 5,415 million USD, adjusted EBIT margin of roughly 16%, and strong bookings of 27.5 billion USD with a 1.3x TTM book‑to‑bill, all ahead of prior expectations. Management’s 2025 revenue guidance is raised to 6–6.3% CC growth and margin guidance to about 15.7%, and the report frames CTSH as successfully traversing a transformation journey with improved competitiveness and Gen‑AI investments, while acknowledging macro volatility and tariff‑related uncertainties; the stock itself is explicitly “not rated” in the piece.